International Clinical Trial: Exploratory study of the targeting efficacy of fibroblast activator protein FAP in primary and metastatic lesions of solid tumors

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134687) titled 'Exploratory study of the targeting efficacy of fibroblast activator protein FAP in primary and metastatic lesions of solid tumors' on Oct. 19.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: The First Affiliated Hospital of Jinan University

Condition: Tumor

Intervention: Gold Standard:CT or MR Imaging diagnosis or local immunohistochemical pathological examination is the gold standard for tumor diagnosis.

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-04-24

Target Sample Size: Target condition:30;Difficult condition:0

Countries o...